medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2021, Number 6

<< Back Next >>

Rev ADM 2021; 78 (6)

Hygiene level and prevalence of Porphyromona gingivalis and Fusobacterium nucleatum in recovered SARS-CoV-2 patients.

Rodríguez-Cardona JL, Álvarez-Fernández WJ, Jiménez-Del VJA, Sánchez-Dorado ME, Urrutia-Baca VH, Cienfuegos-Sarmiento AA, De GMA

Language: Spanish
References: 31
Page: 309-313
PDF size: 195.21 Kb.


ABSTRACT

Introduction: SARS-CoV-2 affects the respiratory system to different degrees. The oral cavity is a colonized place by bacterias, therefore, by not having good hygiene, different secondary diseases can occur; this has caused an alert in the dental industry, since it can contribute to later complications in patients. Material and methods: The study was conducted in 47 SARS-CoV-2 recovered volunteers from the Montemorelos city of the Nuevo León state, Mexico, who were attended at the Bucalia Dent dental clinic. An informed consent was obtained from each of the patients, then their clinical history was documented in order to know the symptoms, previous systemic diseases, absence of teeth and degree of gingival inflammation, as suggested by Loe and Silness. Subsequently, a dental plaque sample was taken from all patients, which was suspended in a phosphate buffered solution and shipped to The Center for Research and Development in Health Sciences (CIDICS), Monterrey, NL, Mexico for storage. DNA extraction and purification was performed and PCR was carried out for the oral pathogens detection. All PCR products were visualized on 1.5% agarose gel by ethidium bromide staining. Results: Porphyromona gingivalis and Fusobacterium nucleatum were detected in 80.85% and 68.09% of SARS-CoV-2 recovered patients, respectively. 23.4% showed mild inflammation based on the Loe and Silness criteria, 54.5% were male and 45.5% female. On the other hand, 36.4% of patients with mild inflammation had between 4 to 6 missing teeth. A single infection by Fusobacterium nucleatum was detected in 18.18% and by Porphyromona gingivalis in 27.27%; the male sex had a predisposition with 66.66% and 33.33% female; coinfection of both pathogens was observed in 45.45% where 60% were male. Conclusions: SARS-CoV-2 recovered patients show poor oral hygiene and a high prevalence of oral pathogens related to the development of inflammatory gingival or periodontal disease, this suggests the need for an odontological clinical intervention at the end of the course of infection or disease caused by SARS-CoV-2.


REFERENCES

  1. Mijovic B. Covid-19–Lessons learned. Scripta Medica. 2020; 51 (1): 1-5.

  2. Ashikujaman Syed. Coronavirus: a mini-review. Int J Curr Res Med Sci. 2020; 6 (1): 8-10.

  3. Perlman S. Another decade, another coronavirus. N Engl J Med. 2020; 382 (8): 760-762.

  4. Gaitán-Cepeda L, Leyva-Huerta E, Cruz-González R, Carmona-Ruiz D, Rodríguez M, Gómez-Arenas A. COVID-19 y el cirujano dentista. Una revisión integral. Rev Odont Mex. 2019; 23 (4): 207-2015.

  5. Abramovitz I, Palmon A, Levy D, Karabucak B, Kot-Limon N, Shay B et al. Dental care during the coronavirus disease 2019 (COVID-19) outbreak: operatory considerations and clinical aspects. Quintessence Int. 2020; 51 (5): 418-429.

  6. Suárez V, Suarez-Quezada M, Oros-Ruiz S, Ronquillo-De Jesús E. Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Rev Clin Esp. 2020; 220 (8): 463-471.

  7. Pacheco MPM, Pacheco GJD, Hernández MAB et al. Consideraciones sobre el diagnóstico de COVID-19 y el papel del diagnóstico salival. Rev ADM. 2020; 77 (4): 191-196.

  8. Dantas-Soares C, Andrade-de Carvalho R, Andrade-de Carvalho K, Goretti-Freire M, Paes-de Almeida O. Letter to editor: oral lesions in a patient with Covid-19. Med Oral Patol Oral Cir Bucal. 2020; 25 (4): e563-e564.

  9. Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis. 2021; 27 Suppl 3: 703-706. doi: 10.1111/odi.13359.

  10. Amorim-Dos Santos J, Normando A, Carvalho-da Silva R, De Paula R, Cembranel A, Santos-Silva A et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020; 97: 326-328.

  11. Baghizadeh Fini M. What dentists need to know about COVID-19. Oral Oncol. 2020; 105: 104741.

  12. Sampson V, Kamona N, Sampson A. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J. 2020; 228 (12): 971-975.

  13. Cruz-Quintana S, Díaz-Sjostrom P, Arias-Socarrás D, Mazón-Baldeón G. Microbiota de los ecosistemas de la cavidad bucal. Rev Cubana Estomatol. 2017; 54 (1): 84-99.

  14. Serrano-Coll HA, Sánchez-Jiménez M, Cardona-Castro N. Conocimiento de la microbiota de la cavidad oral a través de la metagenómica. Rev CES Odont. 2015; 28 (2): 112-118.

  15. Nemeth-Kohanszky M, Matus-Abásolo C, Carrasco-Soto R. Manifestaciones Orales de la Infección por COVID-19. Int J Odontostomat. 2020; 14 (4): 555-560.

  16. Baghizadeh-Fini M. Oral saliva and COVID-19. Oral Oncol. 2020; 108: 104821.

  17. Carreras-Presas M, Amaro-Sánchez J, López-Sánchez A, Jané-Salas E, Somacarrera-Pérez M. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis. 2021; 27 Suppl 3: 710-712. doi: 10.1111/odi.13382.

  18. Sinadinos A, Shelswell J. Oral ulceration and blistering in patients with COVID-19. Evid Based Dent. 2020; 21 (2): 49.

  19. Petrescu N, Lucaciu O, Roman A. Oral mucosa lesions in COVID-19. Oral Dis. 2020; 10.1111/odi.13499.

  20. Riad A, Gomaa M. Comment on: oral manifestation of COVID-19 as an inaugural symptom? Journal of Oral Medicine and Oral Surgery 2020; 26 (2): 19.

  21. Yaumara A, Yayquier D, Leonardo A, Olga G, Orlando L, María S. Infecciones bacterianas asociadas a la COVID-19 en pacientes de una unidad de cuidados intensivos. Rev Med Militar. 2020; 49 (3): e0200793.

  22. Cruz-Quintana S, Díaz-Sjostrom P, Arias-Socarrás D, Mazón-Baldeón G. Microbiota de los ecosistemas de la cavidad bucal. Revista Cubana de Estomatología. 2017; 54 (1): 84-99.

  23. Cervera-Ubierna A. Tratamiento de la infección por SARS-CoV-2. Act Pediatr Mex. 2020; 41 (Supl 1): S121-S126.

  24. Yarzábal-Rodríguez L, Buela-Salazar L, Sarmiento-Ordoñez J. Técnica de biología molecular para la investigación en odontología y biología oral (1a parte). Rev OACTIVA UC. 2018; 3 (1).

  25. Mas E, Poza J, Ciriza J, Zaragoza P, Osta R, Rodellar C. Fundamento de la reacción en cadena de la polimerasa (PCR). Rev AcuaTic. 2016; 15.

  26. Garrote-Santana H, Díaz-Alonso C. Reacción en cadena de la polimerasa cuantitativa: del "Nobel" a la actualidad. Rev Cubana Hematol Inmunol Hemoter. 2019; 35 (4): a_1025.

  27. Cervantes-Gonzalez J. Obtención de ácido desoxirribonucleico (DNA) útil para análisis genético, a partir de uñas recortadas. Rev Med Hered. 2003; 14 (4): 229-232.

  28. Yarzábal-Rodríguez L, Buela-Salazar L, Sarmiento-Ordoñez J. Técnica de biología molecular para la investigación en odontología y biología oral (2a parte). Rev OACTIVA UC. [Internet]. 2019; 4 (3).

  29. Orrego-Cardozo M, Parra-Gil M, Salgado-Morales Y, Muñoz-Guarín E, Fandiño-Henao V. Porphyromonas gingivalis y enfermedades sistémicas. CES Odontol. 2015; 28 (1): 57-73.

  30. Hoffmeister C, Ducasse K, González M, Quilodrán C, Joyas A. Infección pulmonar y torácica por Fusobacterium nucleatum. Andes Pediatr. 2021; 92 (1): 93-98.

  31. Marouf N, Cai W, Said KN, Daas H, Diab H, Chinta VR et al. Association between periodontitis and severity of COVID-19 infection: a case-control study. J Clin Periodontol. 2021; 48: 483-491.




2020     |     www.medigraphic.com